Molecular drivers of lobular carcinoma in situ

[1]  T. Stein,et al.  Mammary Gland Development , 2017, Methods in Molecular Biology.

[2]  L. Qin,et al.  Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion , 2015, Molecular oncology.

[3]  Z. Wang,et al.  Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  T. To,et al.  Is carcinoma in situ a precursor lesion of invasive breast cancer? , 2014, International journal of cancer.

[5]  H. Gobbi,et al.  Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast , 2014, Diagnostic Pathology.

[6]  M. Troxell,et al.  Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions , 2014, Modern Pathology.

[7]  Julian Peto,et al.  Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast , 2014, PLoS genetics.

[8]  A. Wolff,et al.  Treatment of HER2-positive breast cancer. , 2014, Breast.

[9]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[10]  J. Gustafsson,et al.  Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer , 2014, Proceedings of the National Academy of Sciences.

[11]  M. Simpson,et al.  Germline CDH1 mutations in bilateral lobular carcinoma in situ , 2013, British Journal of Cancer.

[12]  Tari A King,et al.  Lobular neoplasia. , 2014, Surgical oncology clinics of North America.

[13]  R. Epstein,et al.  Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy , 2014, BMC Cancer.

[14]  S. Hilsenbeck,et al.  Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy , 2013, eLife.

[15]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[16]  F. Waldman,et al.  Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. , 2013, Human pathology.

[17]  M. Mastropasqua,et al.  DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN). , 2013, Breast.

[18]  J. Cuzick,et al.  Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  I. Ellis,et al.  Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry , 2013, The American journal of surgical pathology.

[20]  A. Degnim,et al.  Surgical management of high-risk breast lesions. , 2013, The Surgical clinics of North America.

[21]  Jaana M. Hartikainen,et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.

[22]  D. de Jong,et al.  CDH1‐related hereditary diffuse gastric cancer syndrome: Clinical variations and implications for counseling , 2012, International journal of cancer.

[23]  A. Vincent-Salomon,et al.  High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients. , 2012, Breast.

[24]  L. Murphy,et al.  The Role of Estrogen Receptor-β in Breast Cancer , 2012, Seminars in Reproductive Medicine.

[25]  V. Seshan,et al.  Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions , 2012, Breast Cancer Research.

[26]  L. Qin,et al.  Cadherin–catenin complex dissociation in lobular neoplasia of the breast , 2012, Breast Cancer Research and Treatment.

[27]  M. Morrow,et al.  Is There a Low-Grade Precursor Pathway in Breast Cancer? , 2012, Annals of Surgical Oncology.

[28]  T. King,et al.  Recommendations for women with lobular carcinoma in situ (LCIS). , 2011, Oncology.

[29]  H. Popper,et al.  Chromosomal aberrations as detected by array comparative genomic hybridization in early low‐grade intraepithelial neoplasias of the breast , 2011, Histopathology.

[30]  M. Glukhova,et al.  The mammary myoepithelial cell. , 2011, The International journal of developmental biology.

[31]  J. Reis-Filho,et al.  Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor‐positive, invasive breast cancer , 2011, The Journal of pathology.

[32]  N. Sneige,et al.  Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. , 2011, Archives of pathology & laboratory medicine.

[33]  M. Rizzo.  Cyclooxygenase-2 in oncogenesis. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[34]  Partha S. Ray,et al.  The Florid Subtype of Lobular Carcinoma In Situ: Marker or Precursor for Invasive Lobular Carcinoma? , 2011, Annals of Surgical Oncology.

[35]  M. Pintilie,et al.  Amplification of the prolactin receptor gene in mammary lobular neoplasia , 2011, Breast Cancer Research and Treatment.

[36]  J. Reis-Filho,et al.  Breast cancer precursors revisited: molecular features and progression pathways , 2010, Histopathology.

[37]  S. Devries,et al.  Genetic and Phenotypic Characteristics of Pleomorphic Lobular Carcinoma In Situ of the Breast , 2009, The American journal of surgical pathology.

[38]  A. Bharat,et al.  Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers. , 2009, American journal of surgery.

[39]  A. Anjomshoaa,et al.  Increased levels of active c-Src distinguish invasive from in situ lobular lesions , 2009, Breast Cancer Research.

[40]  D. Dabbs,et al.  Pleomorphic Lobular Carcinoma In Situ (PLCIS) on Breast Core Needle Biopsies: Clinical Significance and Immunoprofile , 2008, The American journal of surgical pathology.

[41]  Xinyan Wu,et al.  Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9 , 2008, Breast Cancer Research.

[42]  N. Afonso,et al.  Lobular carcinoma in situ , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[43]  I. Ellis,et al.  Morphologic and Molecular Evolutionary Pathways of Low Nuclear Grade Invasive Breast Cancers and Their Putative Precursor Lesions: Further Evidence to Support the Concept of Low Nuclear Grade Breast Neoplasia Family , 2008, The American journal of surgical pathology.

[44]  G. Bratthauer,et al.  Reversed Expression of the JAK/STAT Pathway Related Proteins Prolactin Receptor and STAT5a in Normal and Abnormal Breast Epithelial Cells , 2008, Breast cancer : basic and clinical research.

[45]  Andrew R. Green,et al.  Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast , 2008, Breast Cancer Research and Treatment.

[46]  P. Schirmacher,et al.  Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer , 2008, Breast Cancer Research and Treatment.

[47]  R. Foisner,et al.  The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity , 2007, Oncogene.

[48]  A. Lazaris,et al.  Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia , 2007, Virchows Archiv.

[49]  S. Morini,et al.  COX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breast , 2007, Virchows Archiv.

[50]  S. Morini,et al.  COX‐2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification , 2007, Histopathology.

[51]  R. Foisner,et al.  The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression. , 2007, FEBS letters.

[52]  I. Ellis,et al.  High Frequency of Coexistence of Columnar Cell Lesions, Lobular Neoplasia, and Low Grade Ductal Carcinoma In Situ With Invasive Tubular Carcinoma and Invasive Lobular Carcinoma , 2007, The American journal of surgical pathology.

[53]  Norman Wolmark,et al.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. , 2006, JAMA.

[54]  A. Nobel,et al.  The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.

[55]  V. Eusebi,et al.  Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast , 2006, Virchows Archiv.

[56]  B. Park,et al.  Mutation of the PIK3CA oncogene in human cancers , 2006, British Journal of Cancer.

[57]  V. Eusebi,et al.  The impact of large sections and 3D technique on the study of lobular in situ and invasive carcinoma of the breast , 2006, Virchows Archiv.

[58]  G. Bratthauer,et al.  STAT 5a expression in various lesions of the breast , 2006, Virchows Archiv.

[59]  Adrian V. Lee,et al.  Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  Mitch Dowsett,et al.  Proliferation marker Ki-67 in early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  Teresa L. Mastracci,et al.  E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast , 2005, Modern Pathology.

[62]  K. Malone,et al.  Age-Specific Incidence Rates of In situ Breast Carcinomas by Histologic Type, 1980 to 2001 , 2005, Cancer Epidemiology Biomarkers & Prevention.

[63]  P. O’Connell,et al.  Biomarker profile and genetic abnormalities in lobular carcinoma in situ , 2005, Breast Cancer Research and Treatment.

[64]  S. Devries,et al.  Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma , 2004, Cancer.

[65]  S. Hirohashi,et al.  Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer. , 2004, The American journal of pathology.

[66]  Susan G. Hilsenbeck,et al.  Breast Cancer Patients with Progesterone Receptor PR-A-Rich Tumors Have Poorer Disease-Free Survival Rates , 2004, Clinical Cancer Research.

[67]  I. Christensen,et al.  Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study , 2000, Breast Cancer Research and Treatment.

[68]  R. Elledge,et al.  Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome , 2004, Breast Cancer Research.

[69]  M. Fackler,et al.  DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma , 2003, International journal of cancer.

[70]  J. Herman,et al.  Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E‐cadherin and catenin expression and microsatellite instability , 2003, International journal of cancer.

[71]  S. Lakhani,et al.  The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ , 2003, Breast Cancer Research.

[72]  M. Merino,et al.  Frequent E-cadherin Gene Inactivation by Loss of Heterozygosity in Pleomorphic Lobular Carcinoma of the Breast , 2003, Modern Pathology.

[73]  W. Dupont,et al.  Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study , 2003, The Lancet.

[74]  T. Crook,et al.  The p53 pathway in breast cancer , 2002, Breast Cancer Research.

[75]  G. Bratthauer,et al.  Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications , 2002, Virchows Archiv.

[76]  A. Reynolds,et al.  Regulation of Rho GTPases by p120-catenin. , 2001, Current opinion in cell biology.

[77]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[78]  K. Rieger-Christ,et al.  Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas , 2001, Molecular pathology : MP.

[79]  M. Merino,et al.  Pleomorphic Lobular Carcinoma: Morphology, Immunohistochemistry, and Molecular Analysis , 2000, The American journal of surgical pathology.

[80]  T. Yeatman,et al.  Role of Src expression and activation in human cancer , 2000, Oncogene.

[81]  R. Doherty.  Long term follow up , 1999, BMJ.

[82]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[83]  Yong-jie Lu,et al.  Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. , 1998, Cancer research.

[84]  M. Indelli,et al.  Modulation of biomarkers in minimal breast carcinoma , 1998, Cancer.

[85]  S. Ménard,et al.  THE SPECTRUM OF 67‐kD LAMININ RECEPTOR EXPRESSION IN BREAST CARCINOMA PROGRESSION , 1997, The Journal of pathology.

[86]  G. Colditz,et al.  Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[87]  M. Gnant,et al.  p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. , 1997, European journal of cancer.

[88]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[89]  M. J. van de Vijver,et al.  © 1997 Cancer Research Campaign , 2022 .

[90]  C A Bodian,et al.  Lobular neoplasia: Long term risk of breast cancer and relation to other factors , 1996, Cancer.

[91]  W. Thompson,et al.  Relationship between breast histopathology and family history of breast cancer , 1993, Cancer.

[92]  W. Dupont,et al.  Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. , 1991, Human pathology.

[93]  M. Wick,et al.  Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. , 1989, Human pathology.

[94]  E. Frykberg.  Lobular Carcinoma In Situ of the Breast , 1999, The breast journal.

[95]  R. Millis.  In Situ Lobular Carcinoma , 1984 .

[96]  S. Wellings,et al.  A hypothesis of the origin of human breast cancer from the terminal ductal lobular unit. , 1980, Pathology, research and practice.

[97]  C. Kosloff,et al.  Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow‐up of 24 years , 1978, The American journal of surgical pathology.

[98]  C. Bodian,et al.  Lobular neoplasia (so‐called lobular carcinoma in situ) of the breast , 1978, Cancer.

[99]  J. Rice,et al.  Preneoplastic lesions in the human breast. , 1976, Science.

[100]  H M Jensen,et al.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. , 1975, Journal of the National Cancer Institute.

[101]  J. Andersen,et al.  Lobular carcinoma in situ. A long-term follow-up in 52 cases. , 2009 .

[102]  M. Wunderlich,et al.  [Carcinoma in situ of the female breast]. , 1974, Zentralblatt fur Chirurgie.

[103]  R. Hutter,et al.  Lobular carcinoma in situ. Long term follow‐up , 1969, Cancer.

[104]  R. Hutter,et al.  In situ lobular carcinoma. A prospective follow-up study indicating cumulative patient risks. , 1967, JAMA.

[105]  F. W. Foote,et al.  Classics in oncology: Lobular carcinoma in situ: A rare form of mammary cancer , 1982 .